Evidence — RT3
peptide · asset evidence level: emerging
Evidence quality breakdown (linked documents)
expert_opinion: 1
Linked source documents (1)
- NAD+ — Peptide Protocol Wiki reference (patient_education · expert_opinion)
Provider dosing references (Stage 9, source-attributed)
0.5 mg starting dose, escalating to target of 8-12 mg — Peptide Protocol Wiki (peptideprotocolwiki.com)
Standard: 1 mg once weekly · Low: 1 mg · High: 12 mg — Peptide Dosing Protocols (peptidedosingprotocols.com)
Dosing claims (0) · Safety claims (5)
Extracted claims are provider-review scaffolding, stored verbatim with source attribution — not recommendations or dosing guidance.